Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Isolated regional perfusion in malignant melanoma of the extremities.

Literature DB >> 3630197

Isolated regional perfusion in malignant melanoma of the extremities.

H Schraffordt Koops, J Oldhoff, J W Oosterhuis, H Beekhuis.

Abstract

Entities: Disease

Mesh：

Substances：
Melphalan

Year: 1987 PMID： 3630197 DOI： 10.1007/BF01655819

Source DB: PubMed Journal: World J Surg ISSN： 0364-2313 Impact factor: 3.352

× No keyword cloud information.

27 in total

1. Perfusion chemotherapy for recurrent melanoma of extremity: a progress report.

Authors: W W Shingleton
Journal: Ann Surg Date: 1969-06 Impact factor: 12.969

2. Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbs.

Authors: H Martijn; J Oldhoff; H Schraffordt Koops
Journal: Eur J Cancer Date: 1981-04 Impact factor: 9.162

3. The use of regional chemotherapy in the management of malignant melanoma.

Authors: E T Krementz; R D Carter; C M Sutherland; M Campbell
Journal: World J Surg Date: 1979-07-30 Impact factor: 3.352

4. Eleven years' experience with hyperthermic perfusion for melanoma of the extremities.

Authors: J S Stehlin; B C Giovanella; P D de Ipolyi; R F Anderson
Journal: World J Surg Date: 1979-07-30 Impact factor: 3.352

5. Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.

Authors: E V Sugarbaker; C M McBride
Journal: Cancer Date: 1976-01 Impact factor: 6.860

6. Hyperthermic perfusion in malignant melanoma: 5-year results.

Authors: J Tonak; W Hohenberger; F Weidner; H Göhl
Journal: Recent Results Cancer Res Date: 1983

7. Primary malignant melanoma of the limbs: a re-evaluation using microstaging techniques.

Authors: C M McBride; J L Smith; B W Brown
Journal: Cancer Date: 1981-09-15 Impact factor: 6.860

8. Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion.

Authors: H Schraffordt Koops; H Beekhuis; J Oldhoff; J W Oosterhuis; E van der Ploeg; A Vermey
Journal: Cancer Date: 1981-11-01 Impact factor: 6.860

9. Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanomas of the extremities.

Authors: H Martijn; J Oldhoff; H S Koops
Journal: J Surg Oncol Date: 1982-05 Impact factor: 3.454

10. Comparison of two methods of treating primary malignant melanomas Clark IV and V, thickness 1.5 mm and greater, localized on the extremities. Wide surgical excision with and without adjuvant regional perfusion.

Authors: H Martijn; H Schraffordt Koops; G W Milton; M Nap; J W Oosterhuis; H M Shaw; J Oldhoff
Journal: Cancer Date: 1986-05-15 Impact factor: 6.860

7 in total

Isolated regional perfusion in malignant melanoma of the extremities.

1. Perfusion chemotherapy for recurrent melanoma of extremity: a progress report.

2. Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbs.

3. The use of regional chemotherapy in the management of malignant melanoma.

4. Eleven years' experience with hyperthermic perfusion for melanoma of the extremities.

5. Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.

6. Hyperthermic perfusion in malignant melanoma: 5-year results.

7. Primary malignant melanoma of the limbs: a re-evaluation using microstaging techniques.

8. Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion.

9. Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanomas of the extremities.

10. Comparison of two methods of treating primary malignant melanomas Clark IV and V, thickness 1.5 mm and greater, localized on the extremities. Wide surgical excision with and without adjuvant regional perfusion.

1. Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.

2. The use of isolated limb infusion in limb threatening extremity sarcomas.

3. [Cardiocirculatory side effects of hyperthermic extremity perfusion].

4. Optimization of isolated hyperthermic limb perfusion.

5. Rapid measurement of blood leakage during regional chemotherapy.

6. Hyperthermic isolated limb perfusion for malignant melanoma: response and survival.

7. The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.